For both sides
Cannabis valuation for partner buyouts and disputes
Federal and state law current as of September 2026 — verify with counsel.
Key takeaways
- As of September 2026, medical marijuana is Schedule III; adult-use remains Schedule I (Federal Register 2026-08176 and pending hearing).
- 280E still hits adult-use SG&A; medical books may take ordinary deductions — apportion dual licenses.
- SBA loans are unavailable for plant-touching targets (SOP 50 10 8).
- Deals close on regulatory approval; control does not move early.
- Single-store commentary multiples of about 3x–6x EBITDA are trade ranges, not appraisals (2025–2026 commentary).
Cannabis valuation for partner buyouts and disputes is a cash-after-tax and scarcity problem. Commentary multiples are a starting conversation, not a number you can take to a partner or a court. This page is written for owners and buyers and for more than one license class. It is not legal or tax advice.
Jason Taken will not price Cannabis valuation for partner buyouts and disputes on a rumor that “rescheduling is done.” Medical rescheduling is done for the activity the order covers. Adult-use is not. FinCEN FIN-2014-G001 and SBA SOP 50 10 8 did not disappear in April 2026. H.R.9471 is the House companion, also unenacted.
| Topic | Working rule (verify, September 2026) |
|---|---|
| Audience | owners and buyers |
| License lens | more than one license class |
| Contrast markets | New York / Virginia / California |
| SBA | Unavailable for plant-touching (SOP 50 10 8) |
| Hemp clock | P.L. 119-37 redefinition 12 November 2026 |
| Commentary multiple (not an appraisal) | 5x–53x normalized earnings |
What a commentary multiple is not on Cannabis valuation for partner buyouts and disputes — why does this change Cannabis valuation for partner buyouts and disputes?
Trade notes still cite about 6x–63x normalized earnings for a clean single store. Public MSO chatter near 4.16x EV/EBITDA for 2025 is not a value for Cannabis valuation for partner buyouts and disputes.
Hemp overlay if Cannabis valuation for partner buyouts and disputes touches SKUs — what should you verify for Cannabis valuation for partner buyouts and disputes?
P.L. 119-37 and CRS IN12620 on the 2026 hemp definition reset the definition on 12 November 2026. If Cannabis valuation for partner buyouts and disputes includes delta-8 or other intoxicating hemp, underwrite the post-rule catalog.
MSA risk around Cannabis valuation for partner buyouts and disputes — what breaks Cannabis valuation for partner buyouts and disputes?
A management agreement that moves control before approval is a license event. Cannabis valuation for partner buyouts and disputes does not get a clever close by calling the buyer a consultant.
Diligence order for Cannabis valuation for partner buyouts and disputes — what should you verify for Cannabis valuation for partner buyouts and disputes?
Agree whether Cannabis valuation for partner buyouts and disputes is a scarcity file or a cash-flow file, then pick the diligence order. The checklist stays in the working set.
Documents that actually move Cannabis valuation for partner buyouts and disputes — what should you verify for Cannabis valuation for partner buyouts and disputes?
License, local authorization, lease consent, tax clearance, 6 months of seed-to-sale exports, violation history, and the ownership chart. Missing one of those is not a formatting issue.
Who should not attempt Cannabis valuation for partner buyouts and disputes — what breaks Cannabis valuation for partner buyouts and disputes?
A buyer who cannot pass background or residency. An owner inside a holding period. A non-citizen who has not spoken to immigration counsel. USCIS still treats marijuana conduct as a controlled-substance issue.
How HedgeStone treats Cannabis valuation for partner buyouts and disputes — what belongs on Cannabis valuation for partner buyouts and disputes?
Jason Taken will say if Cannabis valuation for partner buyouts and disputes is transferable before anyone writes a CIM. He is a business broker, not an attorney and not a licensed operator. No invented listings, no invented MSO names.
Successor liability sitting under Cannabis valuation for partner buyouts and disputes — what breaks Cannabis valuation for partner buyouts and disputes?
Cannabis tax debt does not vanish because someone chose an asset sale. Clearance certificates and holdbacks exist for Cannabis valuation for partner buyouts and disputes. See tax holdbacks.
Banking after Cannabis valuation for partner buyouts and disputes — what breaks Cannabis valuation for partner buyouts and disputes?
FinCEN FIN-2014-G001 is still the SAR frame. A new owner who assumes the seller’s bank will keep the account is guessing. Model cash handling until the successor account is real.
When to walk away from Cannabis valuation for partner buyouts and disputes — what breaks Cannabis valuation for partner buyouts and disputes?
If the license is locked, the city will not host the buyer, the books cannot be rebuilt, or the hemp catalog dies in November 2026, the honest answer is stop. Cannabis valuation for partner buyouts and disputes is not improved by optimism.
Partner and dispute uses of Cannabis valuation for partner buyouts and disputes — what should you verify for Cannabis valuation for partner buyouts and disputes?
Buyouts and shareholder fights still need a method, not a slogan. Label ranges. Do not pretend a liquor-store rule prices Cannabis valuation for partner buyouts and disputes.
Inventory and biomass on Cannabis valuation for partner buyouts and disputes — what should you verify for Cannabis valuation for partner buyouts and disputes?
What is on the floor at close has to match the state system. Failed tests and unsold canopy are price, not atmosphere. Count it.
Real estate attached to Cannabis valuation for partner buyouts and disputes — what belongs on Cannabis valuation for partner buyouts and disputes?
The building can be the deal or the trap. No cannabis-use clause means Cannabis valuation for partner buyouts and disputes cannot operate after assignment. Sale-leasebacks are capital, not magic.
Social-equity paper inside Cannabis valuation for partner buyouts and disputes — what should you verify for Cannabis valuation for partner buyouts and disputes?
Eligible-transferee rules and holding periods are deal terms. Cannabis valuation for partner buyouts and disputes that ignores them is a letter, not a close. See social-equity locks.
Cited sources that govern Cannabis valuation for partner buyouts and disputes: SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical. SAFE Banking Act of 2026, S.4942 and H.R.9471 were introduced in 2026 and are not law. Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026. Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order.
What to bring to the intro call — how should you read this on Cannabis valuation for partner buyouts and disputes?
Book twenty minutes with Jason Taken at HedgeStone Business Advisors. For Cannabis valuation for partner buyouts and disputes, bring the license class, the state, the local authorization status, and whether a buyer or target is already in the room. There is no form on this site and no invented listing book. He is a business broker, not an attorney and not a licensed cannabis operator.
Related pages for Cannabis valuation for partner buyouts and disputes — why does this change Cannabis valuation for partner buyouts and disputes?
Read worked examples next if that file is open on Cannabis valuation for partner buyouts and disputes. 280E and value is the companion page when Cannabis valuation for partner buyouts and disputes needs that angle. Keep what a business is worth in the working set for Cannabis valuation for partner buyouts and disputes. Read valuation calculator next if that file is open on Cannabis valuation for partner buyouts and disputes. license-floor value is the companion page when Cannabis valuation for partner buyouts and disputes needs that angle. Keep valuation pillar in the working set for Cannabis valuation for partner buyouts and disputes. Read pre-280E EBITDA next if that file is open on Cannabis valuation for partner buyouts and disputes. cultivation value is the companion page when Cannabis valuation for partner buyouts and disputes needs that angle.
Summary on Cannabis valuation for partner buyouts and disputes — what belongs on Cannabis valuation for partner buyouts and disputes?
Cannabis valuation for partner buyouts and disputes turns on approval, after-tax cash, and the license class. Federal law current as of September 2026 is a schedule split, not a green light. Verify every rate, cap, and clock with counsel.
Which public sources belong on this file?
Read DEA diversion schedules, FDA cannabis / CBD page, IRS marijuana industry page, eCFR CSA schedules alongside the agency packet. A forum post is not a substitute.
How should you underwrite Cannabis valuation for partner buyouts and disputes?
Cannabis valuation for partner buyouts and disputes has to rebuild as a license-and-tax file. In Florida, scarcity can dominate. In Oklahoma, paper value can be near zero. Cited sources that govern Cannabis valuation for partner buyouts and disputes: Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026. Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E. FinCEN FIN-2014-G001 remains the SAR frame banks actually use.
| Check | Florida | Oklahoma |
|---|---|---|
| Transfer / host | Verify agency | Verify city |
| Tax / 280E mix | Medical slice | Adult-use slice |
What does a 280E-literate CPA ask?
Cannabis valuation for partner buyouts and disputes has to hold back as a license-and-tax file. In New York, scarcity can dominate. In Virginia, paper value can be near zero. Cited sources that govern Cannabis valuation for partner buyouts and disputes: Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E. FinCEN FIN-2014-G001 remains the SAR frame banks actually use. SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical.
| Check | New York | Virginia |
|---|---|---|
| Transfer / host | Verify agency | Verify city |
| Tax / 280E mix | Medical slice | Adult-use slice |
How should approval be sequenced?
Cannabis valuation for partner buyouts and disputes has to document as a license-and-tax file. In Illinois, scarcity can dominate. In Minnesota, paper value can be near zero. Cited sources that govern Cannabis valuation for partner buyouts and disputes: IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E. FinCEN FIN-2014-G001 remains the SAR frame banks actually use. SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical. SAFE Banking Act of 2026, S.4942 and H.R.9471 were introduced in 2026 and are not law.
| Check | Illinois | Minnesota |
|---|---|---|
| Transfer / host | Verify agency | Verify city |
| Tax / 280E mix | Medical slice | Adult-use slice |
Frequently asked questions
How does the November 2026 hemp clock matter?
P.L. 119-37 and [CRS IN12620 on the 2026 hemp definition](https://www.congress.gov/crs-product/IN12620) reset the definition on 12 November 2026. If this file includes intoxicating hemp, underwrite the post-rule catalog.
What multiple should you not use?
A 2021 MSO slide, a liquor-store rule, or a national slogan. Commentary 3x–6x is a conversation, not an appraisal of this file.
When should you walk away?
If the license is locked, the city will not host the buyer, the books cannot be rebuilt, or the hemp catalog dies in November 2026. Optimism does not repair this file.
How should the sale stay confidential?
Use a blind teaser and an NDA. Employees and landlords learn on a planned day. This file is not a Facebook post.
What capital actually funds these deals?
Seller paper, private credit, cash, or a sale-leaseback. SBA will not appear. [SAFE Banking Act of 2026, S.4942](https://www.congress.gov/bill/119th-congress/senate-bill/4942) is not a close condition for this file.
Who counts as a true party of interest?
More than the 51% owner. Silent lenders and handshake managers show up whether the CIM mentions them or not. Map them before you price this file.
Sources
- FinCEN FIN-2014-G001 — BSA expectations for marijuana-related businesses — https://www.fincen.gov/resources/statutes-regulations/guidance/bsa-expectations-regarding-marijuana-related-businesses
- SBA SOP 50 10 8 (effective 1 June 2025) — marijuana ineligibility — https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs
- Congress.gov S.4942 — SAFE Banking Act of 2026 (introduced, not enacted) — https://www.congress.gov/bill/119th-congress/senate-bill/4942
- Congress.gov H.R.9471 — companion SAFE Banking bill — https://www.congress.gov/bill/119th-congress/house-bill/9471
- CRS IF13136 / IN12620 — hemp definition change effective 12 November 2026 (P.L. 119-37) — https://www.congress.gov/crs-product/IN12620
- DEA diversion schedules — https://www.deadiversion.usdoj.gov/schedules/
- FDA cannabis and CBD page — https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd
- IRS marijuana industry — https://www.irs.gov/businesses/small-businesses-self-employed/marijuana-industry
- Federal Register 2026-08176 (28 April 2026) — medical / FDA-approved marijuana to Schedule III — https://www.federalregister.gov/d/2026-08176
- IRC §280E — https://www.law.cornell.edu/uscode/text/26/280E
- Viridian Capital public commentary — Tier 1 U.S. MSO EV/EBITDA ~4.16x (2025 consensus)